Stent maker Xtent sets IPO terms
Xtent, a Menlo Park, Calif. company that develops stents to treat coronary artery disease, set its IPO terms at 4.7 million shares for an estimated price of $16 to $18 each.
(This story first posted 1/12)
Next Story: Ethanol use causing corn shortages, spiking price of tortillas
Previous Story: Delayed, Force10 Networks raises $50 million more
